Intellectual property rights, access to life-enhancing drugs, and corporate moral responsibilities

Business Ethics Q 16:233-45 (2006)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,098

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Introduction: Access to Life-Saving Medicines and Intellectual Property Rights.Doris Schroeder - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):277-278.
Intellectual Property and Pharmaceutical Drugs: An Ethical Analysis.of Intellectual Property - 2008 - In Tom L. Beauchamp, Norman E. Bowie & Denis Gordon Arnold (eds.), Ethical Theory and Business. Pearson/Prentice Hall.
The moral responsibilities of stockholders.Richard J. Klonoski - 1986 - Journal of Business Ethics 5 (5):385 - 390.
Monsanto and Intellectual Property Rights.Edward J. Soule - 2001 - Teaching Ethics 2 (1):101-105.

Analytics

Added to PP
2013-12-31

Downloads
3 (#1,729,579)

6 months
1 (#1,516,603)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references